Search Results

Clarian Health named Dr. Philip Dulberger CEO and chief medical officer of its Clarian Saxony Medical Center, which is under construction in Fishers. Dulberger, an anesthesiologist, was hired by Clarian in 2006 to lead the development of the new hospital.

BioCrossroads has elected Darren Carroll, vice president of new ventures at Indianapolis-based Eli Lilly and Co., to the organization’s board of directors. Carroll oversees Lilly’s venture capital investments in the U.S. and Asia. He has previously chaired investment advisory committees for investment funds operated by BioCrossroads, an Indianapolis-based life sciences development group.

Eli Lilly and Co. named Jeffrey Winton its vice president of communications. Beginning Oct. 11, he will report to Bart Peterson, Lilly’s senior vice president of corporate affairs and communications. Winton has worked in communications roles for a variety of pharmaceutical firms, including Bayer Healthcare Pharmaceuticals, Schering-Plough, Pharmacia, Hoffmann-La Roche and American Cyanamid.

Jessica Jochim, a physician assistant, has joined St. Francis Medical Group Vascular Surgeons. She did her medical training at Butler University.

Through Oct. 31
Indiana State Museum

A “coral” reef—consisting of the work of volunteer crocheters from around the state—is displayed through the end of October. But don’t expect it to look exactly the same each time you stop in. Visitors can bring their own pieces—or pick up a handy beginners kit at the Museum—to add to the work, which is an offshore offshoot of “Hyperbolic Crochet Coral Reef Project” created for the Institute for Figuring in Los Angeles. Details here.
 

Roche Diagnostics, which runs its U.S. operations out of Indianapolis, has partnered with IBM to develop a DNA sequencer much faster and cheaper than current technology. Roche and IBM ultimately want to provide a test that performs whole genome sequencing for $100 to $1,000 per test. Such wide access could make genetic sequencing as standard as biopsies, for example, and then allow medical professionals to “personalize” medical treatment based on a person’s genes. As part of the agreement, Roche will fund continued development of the technology at IBM and provide additional resources and expertise through collaboration with Roche’s sequencing subsidiary, Maryland-based 454 Life Sciences. Roche will develop and market all products based on the technology.

Indianapolis-based insurer WellPoint Inc. said its California subsidiary will dial down rate hikes that drew national outrage earlier this year and helped spark a final push for health care reform, according to the Associated Press. WellPoint now plans to raise rates by 14 percent for California individual policyholders. It will cap rate hikes at 20 percent, even though the company said it would lose $100 million on the plans this year. In April WellPoint withdrew increases that averaged 25 percent—and topped out at 39 percent—after consumers and President Barack Obama expressed outrage. WellPoint defended the hikes by saying rising medical costs and healthy people dropping coverage during the recession were forcing it to raise rates. But an outside actuary also found math errors, which prompted last week’s reduction.

About $72 million in construction bids have been awarded so far for the new Wishard Hospital. The contracts total about 14 percent of the entire construction package for the $754 million project, said Matt Gutwein, president and CEO of Health & Hospital Corp. of Marion County, which owns the hospital. He said the new hospital is on schedule and slightly below budget. The 1.2-million-square-foot hospital will be built on 37 acres at the west end of the IUPUI campus. Bids that have been awarded include demolition work, as well as work on a parking garage, the hospital’s foundation and utilities. Wishard hopes to award all contracts by January.